New malaria vaccine ‘safe and well tolerated’ in trials
A new malaria vaccine that tackles the infection at a different stage to those currently on offer has been shown to be “safe and well tolerated” in clinical trials. It is hoped the jab – known as RH5.1/Matrix-M – will “significantly reduce” the number …